Background:  This study aims to explore the clinical utility of Evolocumab in combination with an e-Health System: Swiss Prospective Observational Study in Patients with clinical Atherosclerotic Cardiovascular Disease. Sponsor: Amgen, Switzerland Trial Status: recruiting  Enrolling Centers:  Switzerland Core Study Team: 
© Christian Mueller, 2012 - 2019 │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: Dezember 2019
Home News Team Studies Publications Events Cooperations Contact
ECARA
Dr. Ina Ferel-Harwerth